Mahendra Naidoo
Overview
Explore the profile of Mahendra Naidoo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
92
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee Y, Whitely A, Burling M, Anderson L, Cohen P, Naidoo M, et al.
Int J Gynecol Cancer
. 2025 Feb;
35(2):100052.
PMID: 39971437
Objective: The Rare Ovarian Tumor Module forms part of the National Gynae-Oncology Registry (NGOR) which measures compliance with the optimal care pathways for gynecologic cancer in Australia. Our objectives were...
2.
Holmes Z, Beasley H, Naidoo M, Michael M
BMJ Case Rep
. 2024 Jan;
17(1).
PMID: 38171636
Neuroendocrine tumours (NETs) are rare cancers which often carry significant morbidity and mortality, frequently related to burden of liver metastases. Hyperammonaemia and subsequent hepatic encephalopathy carries a poor prognosis and...
3.
Naidoo M, Piercey O, Tie J
Curr Oncol Rep
. 2021 Nov;
23(12):140.
PMID: 34735665
Purpose Of Review: Improving outcomes for patients with colorectal cancer in both the adjuvant and metastatic setting has been challenging. Here, we review the current and future directions for using...
4.
Naidoo M, Gibbs P, Tie J
Cancers (Basel)
. 2021 Jan;
13(2).
PMID: 33477814
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. While there have been significant developments in the treatments for patients with metastatic CRC in recent years,...
5.
Fleming K, Naidoo M, Wilson M, Flanigan J, Horton S, Kuti M, et al.
Am J Clin Pathol
. 2017 Feb;
147(1):15-32.
PMID: 28158414
Objectives: We review the current status of pathology services in low- and middle-income countries and propose an “essential pathology package” along with estimated costs. The purpose is to provide guidance...
6.
Bahin F, Naidoo M, Williams S, Hourigan L, Ormonde D, Raftopoulos S, et al.
Clin Gastroenterol Hepatol
. 2014 Aug;
13(4):724-30.e1-2.
PMID: 25151254
Background & Aims: Clinically significant postendoscopic mucosal resection bleeding (CSPEB) is the most frequent significant complication of wide-field endoscopic mucosal resection (WF-EMR) of advanced mucosal neoplasia (sessile or laterally spreading...